Potentiating effects of nicorandil on the adenosine A2 receptor-mediated vasodepression in rats: Potential role for KATP channels

Fundamental and Clinical Pharmacology

Volumn 12, Issue 2, 1998, Pages 143-151

  Saito, K ^a   Sakai, K ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Adenosine A1 and A2 receptors; ATP sensitive K+ channel activation; Augmentation of adenosine action; Cromakalim; Nicorandil

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; 6 N CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE 5' (N CYCLOPROPYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; CROMAKALIM; GLIBENCLAMIDE; NICORANDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; 3,7-DIMETHYL-1-PROPARGYLXANTHINE; ADENOSINE RECEPTOR; ANTIHYPERTENSIVE AGENT; DRUG DERIVATIVE; N CYCLOPROPYL ADENOSINE 5' CARBOXAMIDE; N(6) CYCLOPENTYLADENOSINE; N(6)-CYCLOPENTYLADENOSINE; N-CYCLOPROPYL ADENOSINE-5'-CARBOXAMIDE; NICOTINAMIDE; THEOBROMINE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; SPRAGUE DAWLEY RAT;

ADENOSINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROMAKALIM; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; HEART RATE; INJECTIONS, INTRAVENOUS; MALE; NIACINAMIDE; NICORANDIL; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; THEOBROMINE; VASODILATOR AGENTS;

EID: 0031596727     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1998.tb00934.x     Document Type: Article

References (35)

1. Aversano T, Ouyang P, Silverman H. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ Res 1991 ; 69 : 618-22
2. Belloni FL, Hintze TH. Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation. Am J Physiol 1991 ; 261 : H720-7
3. + channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin. J Pharmacol Exp Ther 1991 ; 259 : 526-34
4. 2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol 1986 ; 29 : 331-46
5. Cavero I, Mondot S, Mestre M. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J Pharmacol Exp Ther 1989 ; 248 : 1261-8
6. Clapham JC, Hamilton TC, Longman SD, Buckingham RE, Campbell CA. Antihypertensive and haemodynamic properties of the potassium channel activating (-)enantiomer of cromakalim in animal models. Arzneim-Forsch/Drug Res 1991 ; 41 : 385-91
7. 2 receptor and an intracellular site. Eur J Pharmacol 1983 ; 96 : 61-9
8. + channels. Br J Pharmacol 1997 ; 121 : 1355-63
9. Daut J, Maier-Rudolph W, von Beckerath N, Mehrke G, Gunther K, Goedel-Meinen L. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 1990 ; 247 : 1341-4
10. 2 receptor-mediated vasodepression does not involve a pertussis toxin-sensitive G protein. Eur J Pharmacol 1993 ; 236 : 255-62
11. Gross G, Pieper G, Farber NE, Warltier D, Hardman H. Effects of nicorandil on coronary circulation and myocardial ischemia. Am J Cardiol 1989 ; 63 : 11J-17J
12. Hamilton TC, Weston AH. Cromakalim, nicorandil and pinacidil : novel drugs which open potassium channels in smooth muscle. Gen Pharmacol 1989 ; 20 : 1-9
13. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension 1991 ; 18 : 565-74
14. Kinoshita M, Sakai K. Pharmacology and therapeutic effects of nicorandil. Cardiovasc Drugs Ther 1990 ; 4 : 1075-88
15. Krumenacker M, Roland E. Clinical profile of nicorandil : an overview of its haemodynamic properties and therapeutic efficacy. J Cardiovasc Pharmacol 1992 ; 20 : S93-S102
16. Lefkowitz RJ, Huffman BB, Taylor P. The autonomic and somatic motor nervous systems. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon PW, Gilman AG, eds. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 1995. p 127-8
17. Londos C, Cooper DMF, Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 1980 ; 77 : 2552-4
18. 1-selective adenosine agonist in porcine coronary artery-involvement of potassium channels. J Pharmacol Exp Ther 1992 ; 260 : 437-43
19. Mizumura T, Nithipatikom K, Gross GJ. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res 1995 ; 29 : 482-9
20. Mubagwa K, Mullane K, Flameng W. Role of adenosine in the heart and circulation. Cardiovasc Res 1996 ; 32 : 797-813
21. + Channels in Cardiovascular Medicine. France: Springer-Verlag, 1993. p 95-106
22. + channels in the sustained coronary vasodilator response to adenosine in dogs. Eur J Pharmacol 1993 ; 231 : 185-9
23. Randall MD, Ujiie H, Griffith TM. Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear : an explanation for hypoxic augmentation. Br J Pharmacol 1994 ; 112 : 49-54
24. Saito K, Sakai K. Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with cromakalim. Fundam Clin Pharmacol 1998 ; 12 : 37-43
25. Saito S, Mizumura T, Takayama T, Honye J, Fukui T, Kamata T et al. Antiischemic effects of nicorandil during coronary angioplasty in humans. Cardiovasc Drugs and Therapy 1995 ; 9 : 257-63
26. Sakai K. Nicorandil: animal pharmacology. Am J Cardiol 1989 ; 63 : 2J-10J
27. Sakai K, Saito K, Akima M. Synergistic effect of calcitonin gene-related peptide on adenosine-induced vasodepression in rats. Er J Pharmacol (in press)
28. Seale TW, Abla KA, Shamim MT, Carney JM, Daly JW. 3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sciences 1988 ; 43 ; 1671-84
29. Sebastiao AM, Ribeiro JA. 1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction. Br J Pharmacol 1989 ; 96 : 211-9
30. + channels in arterial smooth muscle. Science 1989 ; 245 : 177-80
31. Stiles GL. Adenosine receptors: structure, function and regulation. Trends Pharmacol Sci 1986 ; 7 : 486-90
32. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 1989 ; 63 : 18J-24J
33. Vegh A, Gyorgyi K, Papp JGy, Sakai K, Parratt JR. Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia. Eur J Pharmacol 1996 ; 305 : 163-8
34. Williams M, Braunwalder A, Erickson TJ. Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopenty-ladenosine (CPA), to rat brain tissue. Naunyn-Schmiedeberg's Arch Pharmacol 1986 ; 332 : 179-83
35. Yao Z, Mizumura T, Mei DA, Gross GJ. KATP channels and memory of ischemic preconditioning in dogs : synergism between adenosine and KATP channels. Am J Physiol 1997 ; 272 : H334-42